SCHEMBL8352845

SCHEMBL8352845

Cc1cnc(Nc2ccccc2)cc1-c1ccc(C(=O)N2CCCCC2)cc1

nearest known ligand 0.65

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 9/20 0.65
▸ CSF1R P07333 1/20 0.52
▸ MAPK14 Q16539 1/20 0.49
▸ HPGD P15428 5/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ ATR Q13535 1/20 0.48
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ NPC1 O15118 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8352126 0.81 GRM5 (0.65) GRM5CSF1RMAPK14HPGDMAPK1
SCHEMBL8349797 0.80 PTPN1 (0.52) MAPK14KDM4EALDH1A1POLBMEN1
SCHEMBL8349130 0.79 MAPK14 (0.52) GRM5MAPK14HPGDALDH1A1MEN1
SCHEMBL14348411 0.79 GRM5 (0.56) GRM5CSF1RHPGDMAPK1ATR
SCHEMBL8351530 0.75 MAPK10 (0.56) GRM5MAPK14
SCHEMBL8351194 0.75 MAPK14 (0.55) MAPK14HPGDMAPK1ALDH1A1RAB9A
SCHEMBL2906631 0.71 PLA2G7 (0.62) MAPK14HPGDMAPK1ALDH1A1POLB
SCHEMBL8351620 0.71 HPGD (0.57) GRM5HPGDALDH1A1HSD17B10TSHR
SCHEMBL22575077 0.70 GRM5 (0.62) GRM5HPGDMAPK1KDM4EALDH1A1
SCHEMBL14348405 0.70 CAMK2D (0.68) GRM5HPGDMAPK1ATRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
WO-2004041789-A1 COMPOSITIONS USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-05-21 — — WO disclosed
Send feedback